Stockreport

Is Pulse Biosciences' (PLSE) Thyroid Cancer Feasibility Study a Prelude to a Broader Platform Strategy? [Yahoo! Finance]

Pulse Biosciences, Inc  (PLSE) 
Last pulse biosciences, inc earnings: 11/7 03:42 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.pulsebiosciences.com
PDF Percutaneous Electrode System using nanosecond pulsed field ablation to treat small papillary thyroid microcarcinoma tumors under 1.5 cm at sites in Florida and Texas. [Read more]